Abstract:"Science means constantly walking a tight rope" Heinrich Rohrer, physicist, 1933. Community-acquired pneumonia (CAP) is the leading cause of death from infectious disease worldwide and disproportionately affects older adults and children. In high-income countries, pneumonia is one of the most common reasons for hospitalisation and (when recurrent) is associated with a risk of developing chronic pulmonary conditions in adulthood. Pneumococcal pneumonia is particularly prevalent in older adults, and here, pneumonia is still associated with significant mortality despite the widespread use of pneumococcal vaccination in middleand high-income countries and a low prevalence of resistant organisms. In older adults, 11% of pneumonia survivors are readmitted within months of discharge, often with a further pneumonia episode and with worse outcomes. In children, recurrent pneumonia occurs in approximately 10% of survivors and therefore is a significant cause of healthcare use. Current antibiotic trials focus on short-term outcomes and increasingly shorter courses of antibiotic therapy. However, the high requirement for further treatment for recurrent pneumonia questions the effectiveness of current strategies, and there is increasing global concern about our reliance on antibiotics to treat infections. Novel therapeutic targets and approaches are needed to improve outcomes. Neutrophils are the most abundant immune cell and among the first responders to infection. Appropriate neutrophil responses are crucial to host defence, as evidenced by the poor outcomes seen in neutropenia. Neutrophils from older adults appear to be dysfunctional, displaying a reduced ability to target infected or inflamed tissue, poor phagocytic responses and a reduced capacity to release neutrophil extracellular traps (NETs); this occurs in health, but responses are further diminished during infection and particularly during sepsis, where a reduced response to granulocyte colony-stimulating factor (G-CSF) inhibits the release of immature neutrophils from the bone marrow. Of note, neutrophil responses are similar in preterm infants. Here, the storage pool is decreased, neutrophils are less able to degranulate, have a reduced migratory capacity and are less able to release NETs. Less is known about neutrophil function from older children, but theoretically, impaired functions might increase susceptibility to infections. Targeting these blunted responses may offer a new paradigm for treating CAP, but modifying neutrophil behaviour is challenging; reducing their numbers or inhibiting their function is associated with poor clinical outcomes from infection. Uncontrolled activation and degranulation can cause significant host tissue damage. Any neutrophil-based intervention must walk the tightrope described by Heinrich Rohrer, facilitating necessary phagocytic functions while preventing bystander host damage, and this is a significant challenge which this review will explore.

Neutrophils in elderly hospitalised community acquired pneumonia patients are immature and migrate inaccurately

Neutrophils in community-acquired pneumonia: parallels in dysfunction at the extremes of age

Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia

Neutrophil-to-Lymphocyte Ratio in Adult Community-Acquired Pneumonia Patients Correlates with Unfavorable Clinical Outcomes

Proteomic profiling of neutrophils and plasma in community-acquired pneumonia reveals crucial proteins in diverse biological pathways linked to clinical outcome

ASSESSMENT OF THE LUNG NEUTROPHILS AND MACROPHAGES FUNCTIONAL STATE IN COMMUNITY-ACQUIRED PNEUMONIA

Analysis of etiology and prognostic factors of community acquired pneumonia in elderly patients

Analysis of Clinical Features of Elderly Patients with Community-Acquired Pneumonia

Study of Absolute Neutrophil Absolute Lymphocyte count ratio in Community Acquired Pneumonia patients as a prognostic indicator at a tertiary care centre

CD4+ T cells related to disease severity in elderly and frailty community‐acquired pneumonia patients: A retrospective cohort study

Weakened airway epithelial junctions and enhanced neutrophil elastase release contribute to age-dependent bacteremia risk following pneumococcal pneumonia

Oxidative metabolism of neutrophils in patients with community-acquired pneumonia

Changes in Neutrophil Metabolism upon Activation and Aging

Effect of age on human neutrophil function

Clinical Analysis of 44 Patients with Community-Acquired Pneumonia in Very Elderly

Age-dependent inflammatory response is altered in an ex vivo model of bacterial pneumonia

Ageing results in an exacerbated inflammatory response to LPS by resident lung cells

T Cell Responses in Senior Patients with Community-Acquired Pneumonia Related to Disease Severity.

Activating A1 adenosine receptor signaling boosts early pulmonary neutrophil recruitment in aged mice in response to Streptococcus pneumoniae infection

Neutrophil Recruitment in Pneumococcal Pneumonia

Common Syndromes of Community Acquired Pneumonia and Analysis on Characteristics of Elderly Patients